Phase 1 Locally Advanced Pancreatic Adenocarcinoma trials recruiting now
All Locally Advanced Pancreatic Adenocarcinoma trials, every phase
5
Phase 1 recruiting
Other phases for Locally Advanced Pancreatic Adenocarcinoma
Phase 1 Locally Advanced Pancreatic Adenocarcinoma trials
- A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
- AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
- Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma
- Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.